Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Sets The Stage For A Biosimilar Showdown Over Exclusive Contracts

Sep 20 2017

Gavel_1200x675

Related Content

Too Bold By Half: Allergan’s Latest Moves And Pharma’s Leadership Deficit

Sep 12 2017

Pfizer Will Support Inflectra Launch With Dedicated Sales Force

Nov 14 2016

Remicade: Biosimilars And Pricing Pressure Wear On J&J's Blockbuster Brand

Jul 18 2017

Exclusive Remicade Contracts Are Slowing Biosimilar Uptake

Aug 01 2017

Related Companies

Pfizer Inc.

Johnson & Johnson

Celltrion, Inc.

Allergan plc

Anthem Inc.

Cigna Corp.

Additional Topics

Biosimilars Legal Issues Market Access Pricing Strategies Reimbursement Commercial BioPharmaceutical

More from Legal & IP

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.